| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |